Yingting Liu
Overview
Explore the profile of Yingting Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Chen J, Li A, Wu Y, Ge J, Yuan M, et al.
Front Immunol
. 2025 Jan;
15:1430136.
PMID: 39822248
While biomarkers have been shown to enhance the prognosis of patients with colorectal cancer (CRC) compared to conventional treatments, there is a pressing need to discover novel biomarkers that can...
2.
Wu S, Jiao J, Wang N, He N, Wu Y, Jiang H, et al.
Int Immunopharmacol
. 2024 Oct;
143(Pt 2):113330.
PMID: 39423663
Background: Thermal ablation (TA), including radiofrequency ablation (RFA) and Microwave ablation (MWA) could reduce tumor burden and can stimulate an immune response, but it cannot maintain a lasting immune response....
3.
He N, Huang H, Wu S, Ji W, Tai Y, Gao R, et al.
Cancer Sci
. 2024 Apr;
115(7):2196-2208.
PMID: 38655660
Although microwave ablation (MWA) is an important curative therapy in colorectal cancer liver metastasis, recurrence still occurs clinically. Our previous studies have shown that the expression of programmed cell death...
4.
Lang Y, Huang H, Jiang H, Wu S, Chen Y, Xu B, et al.
J Immunother
. 2024 Mar;
47(5):172-181.
PMID: 38545758
Immune checkpoint blockade therapy is a pivotal approach in treating malignant tumors. TIGIT has emerged as a focal point of interest among the diverse targets for tumor immunotherapy. Nonetheless, there...
5.
Yan F, Da Q, Yi H, Deng S, Zhu L, Zhou M, et al.
NPJ Precis Oncol
. 2024 Mar;
8(1):76.
PMID: 38538739
Diffuse large B cell lymphoma (DLBCL) is an aggressive blood cancer known for its rapid progression and high incidence. The growing use of immunohistochemistry (IHC) has significantly contributed to the...
6.
Huang H, Ge J, Fang Z, Wu S, Jiang H, Lang Y, et al.
Front Immunol
. 2024 Mar;
15:1362140.
PMID: 38510246
Exhausted CD8T cells represent a distinct cellular lineage that emerges during both chronic infections and cancers. Recent studies have shown that persistent antigen exposure can drive the differentiation of precursor...
7.
Chen L, Huang H, Huang Z, Chen J, Liu Y, Wu Y, et al.
World J Surg Oncol
. 2023 Apr;
21(1):124.
PMID: 37024870
Background: Tissue-resident CD8T cells (CD103CD8T cells) are the essential effector cell population of anti-tumor immune response in tissue regional immunity. And we have reported that IL-33 can promote the proliferation...
8.
Xiao W, Huang H, Zheng P, Liu Y, Chen Y, Chen J, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900218
As a practical local therapeutic approach to destroy tumor tissue, thermal ablation can activate tumor-specific T cells via enhancing tumor antigen presentation to the immune system. In the present study,...
9.
Li X, Liu H, Zhang Y, Liu Y
Asian J Surg
. 2023 Feb;
46(7):2936-2937.
PMID: 36841625
No abstract available.
10.
Yi H, Li A, Ouyang B, Da Q, Dong L, Liu Y, et al.
Histopathology
. 2022 Dec;
82(4):567-575.
PMID: 36494712
Aims: Indolent natural killer (NK) cell lymphoproliferative disorder of the gastrointestinal (GI) tract (iNKLPD) is a rare, recently recognised neoplasm. Most of the reported tumours are confined to the GI...